Advanced in Heart Failure with Preserved Ejection Fraction (HFpEF)

Lars S. Maier

Franz Josef Strauss Allee 11, 
Regensburg, BY, DE 
Advanced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Franz Josef Strauss Allee 11, 
Regensburg, BY, DE 
OverviewLocationsClinical Research

Overview

Lars Maier practices in Regensburg, Germany. Mr. Maier is rated as an Advanced expert by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Heart Failure, Central Sleep Apnea, Atrial Fibrillation, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG).

His clinical research consists of co-authoring 357 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 17 articles in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Gender
Male

Locations

Franz Josef Strauss Allee 11, Regensburg, BY, Germany
Other Locations
Franz Josef Strauss Allee 11, Regensburg, BY 93055, Germany
Robert Koch Str. 40, Goettingen, NI 37075, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Randomized, Multi-Center, Event-Driven Trial of TAVI Versus SAVR in Patients With Symptomatic Severe Aortic Valve Stenosis and Intermediate Risk of Mortality, as Assessed by STS-Score - DEDICATE
Randomized, Multi-Center, Event-Driven Trial of TAVI Versus SAVR in Patients With Symptomatic Severe Aortic Valve Stenosis and Intermediate Risk of Mortality, as Assessed by STS-Score - DEDICATE
Enrollment Status: Active_not_recruiting
Publish Date: April 26, 2024
Intervention Type: Device, Procedure
Study Phase: Not Applicable

357 Total Publications

Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.
Journal: The New England journal of medicine
Published: September 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Maier's expertise for a condition
ConditionClose
    View All 13 Advanced Conditions
    View All 49 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile